Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma

Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical significance of erythropoietin receptor (EPOR) signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Rózsás, Anita, Berta, Judit, Rojkó, Lívia, Horváth, László Z., Keszthelyi, Magdolna, Kenessey, István, László, Viktória, Berger, Walter, Grusch, Michael, Hoda, Mir Alireza, Török, Szilvia, Klepetko, Walter, Rényi-Vámos, Ferenc, Hegedűs, Balázs, Döme, Balázs, Tóvári, József
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796497/
https://www.ncbi.nlm.nih.gov/pubmed/24155958
http://dx.doi.org/10.1371/journal.pone.0077459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796497/
https://www.ncbi.nlm.nih.gov/pubmed/24155958
http://dx.doi.org/10.1371/journal.pone.0077459

Ejemplares similares